Table 3 Expression of AdipoR2 and clinicopathological characteristics in gastric cancer patients.
From: Adiponectin receptor-1 expression is associated with good prognosis in gastric cancer
| Â | AdipoR2 positive (n = 72) | AdipoR2 negative (n = 28) | p value |
|---|---|---|---|
Age (y) | 62.1 ± 12.3 | 60.7 ± 14.2 | 0.624 |
Gender | Â | Â | Â |
   Male | 52 | 14 | 0.035 |
   Female | 20 | 14 |  |
BMI | 22.9 ± 3.9 | 23.1 ± 3.8 | 0.719 |
Serum adiponectin (μg/ml) | 7.9 ± 5.5 | 8.0 ± 5.1 | 0.968 |
Macroscopic type | Â | Â | Â |
   Elevated | 10 | 1 | 0.139 |
   Depressed/flat | 62 | 27 |  |
Depth of invasion | Â | Â | Â |
   T1 | 33 | 13 | 0.957 |
   T2, T3 and T4 | 39 | 15 |  |
Histological type | Â | Â | Â |
   differentiated | 36 | 4 | 0.001 |
   undifferentiated | 36 | 24 |  |
Lymphatic invasion | Â | Â | Â |
   positive | 55 | 19 | 0.382 |
   negative | 17 | 9 |  |
Venous invasion | Â | Â | Â |
   positive | 41 | 14 | 0.531 |
   negative | 31 | 14 |  |
Lymphatic metastasis | Â | Â | Â |
   positive | 42 | 15 | 0.666 |
   negative | 30 | 13 |  |
Peritoneal dissemination | Â | Â | Â |
   positive | 11 | 6 | 0.462 |
   negative | 61 | 22 |  |
Stage | Â | Â | Â |
   I and II | 46 | 21 | 0.289 |
   III and IV | 26 | 7 |  |